Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. (Q52210193)

27 April 2018

http://europepmc.org/abstract/MED/10392984

title

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. (English)

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

0 references

J Durant

1

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

P Clevenbergh

2

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

P Halfon

3

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

P Delgiudice

4

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

S Porsin

5

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

P Simonet

6

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

N Montagne

7

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

C A Boucher

8

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

J M Schapiro

9

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

P Dellamonica

10

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

language of work or name

English

0 references

publication date

1 June 1999

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

published in

The Lancet

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

volume

353

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

issue

9171

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

page(s)

2195-2199

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

cites work

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912291-2

7 January 2021

HIV treatment failure: testing for HIV resistance in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912291-2

7 January 2021

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912291-2

7 January 2021

Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912291-2

7 January 2021

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912291-2

7 January 2021

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912291-2

7 January 2021

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912291-2

7 January 2021

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912291-2

7 January 2021

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912291-2

7 January 2021

CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912291-2

7 January 2021

10.1016/S0140-6736(98)12291-2

Identifiers

DOI

1 reference

27 April 2018

http://europepmc.org/abstract/MED/10392984

1 reference

27 April 2018